Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-05-15 @ 4:14 PM
Study NCT ID:
NCT04399551
Status:
COMPLETED
Last Update Posted:
2024-04-05
First Post:
2020-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
Sponsor:
ViiV Healthcare
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |